COMPASS Pathways Ownership | Who Owns COMPASS Pathways?
COMPASS Pathways Ownership Summary
COMPASS Pathways is owned by 55.41% institutional investors, 13.30% insiders, and 31.29% retail investors. Deep track capital, lp is the largest institutional shareholder, holding 9.46% of CMPS shares. ARK Genomic Revolution ETF is the top mutual fund, with 1.99% of its assets in COMPASS Pathways shares.
CMPS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | COMPASS Pathways | 55.41% | 13.30% | 31.29% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Medical Care Facilities Stocks | 75.76% | 12.33% | 11.91% |
Idea | Psychedelic Stocks List | 41.93% | 14.87% | 43.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Deep track capital, lp | 8.83M | 9.46% | $24.73M |
Rtw investments, lp | 8.22M | 8.81% | $23.02M |
Millennium management | 3.41M | 4.99% | $12.90M |
Nantahala capital management | 4.18M | 4.48% | $11.70M |
Vivo capital | 3.36M | 3.60% | $9.41M |
Gmt capital | 1.78M | 1.91% | $4.99M |
Pfm health sciences, lp | 1.78M | 1.91% | $4.98M |
Ark investment management | 1.65M | 1.77% | $4.62M |
Ally bridge group (ny) | 1.49M | 1.59% | $4.16M |
Tang capital management | 1.30M | 1.39% | $3.64M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Founders fund vii management | 278.88K | 100.00% | $1.05M |
Ally bridge group (ny) | 1.49M | 3.46% | $4.16M |
22nw, lp | 882.84K | 1.56% | $2.47M |
Rosalind advisors | 707.63K | 1.37% | $2.67M |
Vivo capital | 3.36M | 0.96% | $9.41M |
Aisling capital management lp | 1.20M | 0.93% | $3.36M |
Deep track capital, lp | 8.83M | 0.79% | $24.73M |
Dafna capital management | 811.05K | 0.63% | $2.27M |
Nantahala capital management | 4.18M | 0.46% | $11.70M |
Pfm health sciences, lp | 1.78M | 0.43% | $4.98M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | 8.22M | 0.33% | 2.68M |
Ally bridge group (ny) | 1.49M | 3.46% | 1.49M |
Nantahala capital management | 4.18M | 0.46% | 1.35M |
Pfm health sciences, lp | 1.78M | 0.43% | 1.33M |
Boothbay fund management | 700.00K | 0.04% | 637.70K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Tcg crossover management | - | - | -3.86M |
Laurion capital management lp | - | - | -1.76M |
Altium capital management lp | - | - | -1.42M |
Paradigm biocapital advisors lp | - | - | -1.16M |
Logos global management lp | - | - | -1.16M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Ally bridge group (ny) | 1.49M | 3.46% | 1.49M | $4.16M |
Schroder investment management group | 544.72K | 0.00% | 544.72K | $1.53M |
Toronto dominion bank | 500.00K | 0.00% | 500.00K | $1.40M |
Susquehanna portfolio strategies | 399.96K | 0.02% | 399.96K | $1.12M |
Stableford capital ii | 163.94K | 0.27% | 163.94K | $709.87K |
Sold Out
Holder | Change |
---|---|
American capital advisory | -5.00 |
Ifp advisors | -10.00 |
Corecap advisors | -10.00 |
Nelson, van denburg & campbell wealth management group | -15.00 |
Jamison private wealth management | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 150 | 7.14% | 51,720,681 | 3.71% | 55 | 1.77% | 61 | -1.61% | 38 | 40.74% |
Mar 31, 2025 | 142 | 5.19% | 51,907,706 | 67.77% | 58 | 2.84% | 64 | 8.47% | 26 | - |
Dec 31, 2024 | 114 | -17.99% | 18,014,918 | -45.03% | 26 | 1.15% | 52 | - | 21 | -19.23% |
Sep 30, 2024 | 137 | 4.58% | 32,772,645 | 15.26% | 47 | 2.77% | 52 | - | 26 | 36.84% |
Jun 30, 2024 | 130 | 5.69% | 28,432,133 | 3.56% | 44 | 2.25% | 51 | 10.87% | 19 | -26.92% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
ARK Genomic Revolution ETF | 1.91M | 1.99% | -11.47K |
ARK Genomic Revolution | 1.61M | 1.68% | -164.64K |
HSBC GIF Glb Eq Sust Hlthcare AC USD | 1.08M | 1.12% | 1.08M |
International Biotechnology Ord | 643.07K | 0.67% | 98.35K |
Nikko Gbl All Biological Genome Eq MF | 316.75K | 0.46% | -67.45K |
Columbia Small Cap Value I A | 392.51K | 0.41% | 392.51K |
iShares Biotechnology ETF | 326.43K | 0.34% | 2.79K |
Putnam Sustainable Future A | 162.90K | 0.24% | - |
TEQ - Disruptive Technologies - I-II | 213.71K | 0.22% | 65.85K |
AdvisorShares Psychedelics ETF | 206.66K | 0.22% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
Sep 26, 2024 | ATAI Life Sciences N.V. | - | Sell | $16.09M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | 4 |
2024 Q3 | - | 1 |
CMPS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools